COMMUNIQUÉS West-GlobeNewswire

Teladoc Health highlights progress in advancing care access, sustainability in new report
18/01/2024
Industry leader releases fourth annual Corporate Social Responsibly (CSR) report PURCHASE, NY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, today [...]
TerrAscend to Present at the FONDS PROFESSIONELL KONGRESS in Germany on January 25th
18/01/2024
TORONTO, Jan. 18, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that its executive management team will [...]
NEXGEL to Present at The Microcap Conference, January 30th through February 1st
18/01/2024
LANGHORNE, Pa., Jan. 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer [...]
Cannabix Quantifies Marijuana Breath Samples from Maryland Green Lab – Results Analyzed at North Louisiana Criminalistics Laboratory
18/01/2024
VANCOUVER, British Columbia, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices reports that [...]
Elevar Therapeutics To Present Two Posters From Phase 3 CARES-310 Study at 2024 ASCO Gastrointestinal Cancers Symposium
18/01/2024
A post hoc analysis found the efficacy of camrelizumab plus rivoceranib was superior to sorafenib regardless of baseline liver function as measured by both albumin-bilirubin grade and Child-Pugh class Another analysis, [...]
Surrozen Provides Corporate Update on Clinical Programs
18/01/2024
Announces strategic prioritization of clinical programs to focus on development of SZN-043 for Alcohol-Associated Hepatitis SZN-043 - Completed enrollment for the Phase 1a clinical trial in chronic liver disease [...]
XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition
18/01/2024
XOMA provided an $8 million non-dilutive royalty capital solution to Talphera XOMA will receive a 15% royalty on all commercial sales and a significant portion of the 75% royalty generated by U.S. Department of Defense [...]
Adial Announces Appointment of Tony Goodman as Chief Operating Officer
18/01/2024
Highly Experienced Pharma Commercial and Business Development Executive in Addiction Treatment Space Joins Leadership Team While Continuing as Board Member Charlottesville, Va., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Adial [...]
UK’s largest independent chemical manufacturer takes drug testing in-house with Intelligent Fingerprinting Drug Screening System
18/01/2024
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
Lisata Therapeutics to Present at the Sequire Investor Summit in Puerto Rico
18/01/2024
BASKING RIDGE, NJ, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of [...]
Accelus Announces Closing of $20 Million Debt Facility with Symbiotic Capital
18/01/2024
Cash infusion to provide company with additional resources for accelerated growth PALM BEACH GARDENS, Fla., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Accelus , a privately held medical technology company committed to becoming [...]
Panbela Announces Publication of Clinical Data Titled: Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
18/01/2024
A Phase 1 clinical study showed that high dose DFMO treatment in combination with chemotherapy may provide therapeutic benefits to heavily pretreated patients with neuroblastoma. MINNEAPOLIS, Jan. 18, 2024 (GLOBE [...]
iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024
18/01/2024
LEXINGTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a [...]
Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida
18/01/2024
CAPE CANAVERAL, Fla., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a U.S. company pioneering the development of a new class of medicines, today announced a collaboration with the University of [...]
Canadian Men’s Health Foundation reports that more men are addressing stress, anxiety and depression
18/01/2024
Use of the MindFit Toolkit supported a 13x increase in counselling services completed at no-cost last year with continued growth expected in 2024 VANCOUVER, British Columbia, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The [...]
Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast
18/01/2024
Call scheduled for Monday, February 12th at 4:30 pm Eastern Time GARDEN CITY, N.Y., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device [...]
LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference
18/01/2024
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the Maxim Group 2024 Healthcare IT Virtual Conference, being held [...]
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
18/01/2024
Dr. Frederick to advise Company on corporate affairs and commercial strategy for efzofitimod in interstitial lung disease (ILD). SAN DIEGO, Jan. 18, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or “ [...]
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
18/01/2024
POMPANO BEACH, Fla., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Curonix LLC, a medical technology company dedicated to easing chronic pain without the use of opioids, and Sure Med Compliance, a digital healthcare company focused [...]

Pages